These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2653935)

  • 1. Effect of interferon on glucose tolerance and insulin sensitivity.
    Koivisto VA; Pelkonen R; Cantell K
    Diabetes; 1989 May; 38(5):641-7. PubMed ID: 2653935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin secretion and cellular glucose metabolism after prolonged low-grade intralipid infusion in young men.
    Jensen CB; Storgaard H; Holst JJ; Dela F; Madsbad S; Vaag AA
    J Clin Endocrinol Metab; 2003 Jun; 88(6):2775-83. PubMed ID: 12788887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute effects of ghrelin on insulin secretion and glucose disposal rate in gastrectomized patients.
    Damjanovic SS; Lalic NM; Pesko PM; Petakov MS; Jotic A; Miljic D; Lalic KS; Lukic L; Djurovic M; Djukic VB
    J Clin Endocrinol Metab; 2006 Jul; 91(7):2574-81. PubMed ID: 16621911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence against important catecholamine compensation for absent glucagon counterregulation.
    De Feo P; Perriello G; Torlone E; Fanelli C; Ventura MM; Santeusanio F; Brunetti P; Gerich JE; Bolli GB
    Am J Physiol; 1991 Feb; 260(2 Pt 1):E203-12. PubMed ID: 1996624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute cortisol excess results in unimpaired insulin action on lipolysis and branched chain amino acids, but not on glucose kinetics and C-peptide concentrations in man.
    Clerc D; Wick H; Keller U
    Metabolism; 1986 May; 35(5):404-10. PubMed ID: 3517554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon-alpha reduces insulin resistance and beta-cell secretion in responders among patients with chronic hepatitis B and C.
    Tai TY; Lu JY; Chen CL; Lai MY; Chen PJ; Kao JH; Lee CZ; Lee HS; Chuang LM; Jeng YM
    J Endocrinol; 2003 Sep; 178(3):457-65. PubMed ID: 12967337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Independent measures of insulin secretion and insulin sensitivity during the same test: the glucagon-insulin tolerance test.
    Dorkhan M; Tripathy D; Malm G; Asgharian H; Tuomi T; Groop L
    J Intern Med; 2008 Jul; 264(1):62-71. PubMed ID: 18298489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of physiologic hyperinsulinemia on glucose and lipid metabolism in cirrhosis.
    Petrides AS; Groop LC; Riely CA; DeFronzo RA
    J Clin Invest; 1991 Aug; 88(2):561-70. PubMed ID: 1864966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of cortisol to glucose counterregulation in humans.
    De Feo P; Perriello G; Torlone E; Ventura MM; Fanelli C; Santeusanio F; Brunetti P; Gerich JE; Bolli GB
    Am J Physiol; 1989 Jul; 257(1 Pt 1):E35-42. PubMed ID: 2665516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sulfonylurea therapy fails to diminish insulin resistance in type I-diabetic subjects.
    Keller U; Müller R; Berger W
    Horm Metab Res; 1986 Sep; 18(9):599-603. PubMed ID: 2946637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired basal glucose effectiveness but unaltered fasting glucose release and gluconeogenesis during short-term hypercortisolemia in healthy subjects.
    Nielsen MF; Caumo A; Chandramouli V; Schumann WC; Cobelli C; Landau BR; Vilstrup H; Rizza RA; Schmitz O
    Am J Physiol Endocrinol Metab; 2004 Jan; 286(1):E102-10. PubMed ID: 12965873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of endocrine counterregulation for estimating insulin sensitivity from intravenous glucose tolerance tests.
    Brehm A; Thomaseth K; Bernroider E; Nowotny P; Waldhäusl W; Pacini G; Roden M
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2272-8. PubMed ID: 16595595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Important role of adrenergic mechanisms in acute glucose counterregulation following insulin-induced hypoglycemia in type I diabetes. Evidence for an effect mediated by beta-adrenoreceptors.
    Bolli G; de Feo P; Compagnucci P; Cartechini MG; Angeletti G; Santeusanio F; Brunetti P
    Diabetes; 1982 Jul; 31(7):641-7. PubMed ID: 6298039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nocturnal elevation of glucose levels during fasting in noninsulin-dependent diabetes.
    Shapiro ET; Polonsky KS; Copinschi G; Bosson D; Tillil H; Blackman J; Lewis G; Van Cauter E
    J Clin Endocrinol Metab; 1991 Feb; 72(2):444-54. PubMed ID: 1991813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucagonostatic actions and reduction of fasting hyperglycemia by exogenous glucagon-like peptide I(7-36) amide in type I diabetic patients.
    Creutzfeldt WO; Kleine N; Willms B; Orskov C; Holst JJ; Nauck MA
    Diabetes Care; 1996 Jun; 19(6):580-6. PubMed ID: 8725855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin sensitivity and body composition in cirrhosis: changes after TIPS.
    Holland-Fischer P; Nielsen MF; Vilstrup H; Tønner-Nielsen D; Mengel A; Schmitz O; Grønbaek H
    Am J Physiol Gastrointest Liver Physiol; 2010 Aug; 299(2):G486-93. PubMed ID: 20489042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of stress hormones on splanchnic substrate and insulin disposal after glucose ingestion in healthy humans.
    Waldhäusl WK; Gasic S; Bratusch-Marrain P; Komjati M; Korn A
    Diabetes; 1987 Feb; 36(2):127-35. PubMed ID: 3542641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of prolonged pulsatile hyperinsulinemia in humans. Enhancement of insulin sensitivity.
    Ward GM; Walters JM; Aitken PM; Best JD; Alford FP
    Diabetes; 1990 Apr; 39(4):501-7. PubMed ID: 2180760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The intra-nasal administration of insulin induces significant hypoglycaemia and classical counterregulatory hormonal responses in normal man.
    Paquot N; Scheen AJ; Franchimont P; Lefebvre PJ
    Diabete Metab; 1988; 14(1):31-6. PubMed ID: 3292305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bedtime insulin for suppression of overnight free-fatty acid, blood glucose, and glucose production in NIDDM.
    Taskinen MR; Sane T; Helve E; Karonen SL; Nikkilä EA; Yki-Järvinen H
    Diabetes; 1989 May; 38(5):580-8. PubMed ID: 2653929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.